Tenax Therapeutics (TENX) Total Liabilities (2011 - 2026)

Tenax Therapeutics (TENX) has 15 years of Total Liabilities data on file, last reported at $8.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 206.58% year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (up 206.58% YoY), and the FY2025 full-year result was $7.2 million, up 52.48% from the prior year.
• Total Liabilities advanced to $8.5 million in Q1 2026, from $7.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $8.5 million in Q1 2026 to a low of $602214.0 in Q3 2023.
• A 5-year average of $3.0 million and a median of $2.1 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities tumbled 53.58% in 2023 and jumped 325.38% in 2024, its largest moves.
• Tracing TENX's Total Liabilities over 5 years: stood at $1.9 million in 2022, then jumped by 87.61% to $3.6 million in 2023, then soared by 30.83% to $4.7 million in 2024, then soared by 52.48% to $7.2 million in 2025, then climbed by 18.59% to $8.5 million in 2026.
• Business Quant data shows TENX's Total Liabilities at $8.5 million in Q1 2026, $7.2 million in Q4 2025, and $6.6 million in Q3 2025.